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  INTRODUCTION 
The demonstrated association between infection and 
autoimmunity in genetically predisposed individuals1, 
has opened the debate in the scientific community 
about the possibility that vaccines may also induce 
autoimmune phenomena.2 There are numerous 
reports of patients who have developed autoimmune 
diseases after certain vaccinations, which raises the 
suspicion of a causal relationship, but there are 
several epidemiological studies that have not 
confirmed this association, which has led to intense 
debate on this topic.3 The possibility that a vaccine is 
capable of inducing an autoimmune event must not 
be overlooked, although the magnitude of the 
potential risk is apparently low. There is currently still 
limited knowledge related to the etiology, genetic 
basis and other risk factors that are part of the mosaic 
of autoimmune diseases, so this is a field of intense 
research followed closely by health and regulatory 
entities in all countries.  
 
There are various models of autoimmune diseases, 
induced in laboratory animals by immunization with 
antigens obtained from their own tissues formulated 
with adjuvants. A classic example is the experimental 
allergic encephalitis model, which is obtained in 
susceptible rat and mouse lines, by inoculating tissue 
extracts from the central nervous system, myelin 
basic protein, or peptides derived from it with 
Freund’s Complete Adjuvant, resulting in 
characteristic neurological symptoms.4 Other models 
have been described  to  reproduce  an  autoimmune   
 
disease  in laboratory animals, following similar 
protocols.5 However, it has been described that 
inoculation of a peptide from the hepatitis B virus 
polymerase, which shares sequential similarities to 
rabbit MBP, by being inoculated with this, produced 
perivascular infiltration localized in the central 
nervous system, similar to that occurring with 
inoculation of full-length MBP or encephalitogenic 
peptides derived from it, further demonstrating a 
humoral and cellular immune response against MBP 
itself.6  
 
Experimental models provide a basis for studying the 
mechanisms of a potential development of post-
vaccine autoimmune disease. However, it should be 
considered that such models do not reproduce exactly 
what happens when a vaccine is given in humans, 
since they are based on immunization regimens 
under extreme conditions, using adjuvants such as 
Freund’s, not approved for clinical use; in addition, 
genetically susceptible models are almost always used 
and immunized with purified organ or self-antigen 
homogenates, which does not occur in practice. There 
are numerous suspected cases of post-vaccination 
autoimmune diseases documented in the medical 
literature. Similarly, there are periodic databases and 
publications that record adverse events associated 
with vaccines that allow the causal relationship 
between vaccines and their adverse effects to be 
processed and statistically analyzed, including post-
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suspected association of hepatitis B vaccines with 
signs of central nervous system demyelination in 
humans was recorded in 1991.8 Then, in France, 35 
cases of demyelinating diseases were described, 
occurring within eight weeks after a similar 
vaccination was given, with half of the cases being 
confirmed as multiple sclerosis.9 The accumulation of 
spontaneous multiple sclerosis cases led the French 
Minister of Public Health to temporarily prohibit the 
vaccination program of schoolchildren with the 
hepatitis B vaccine initiated in 1995, which coupled 
with the absence of epidemiological data 
demonstrating otherwise, created much debate and 
confusion.10 Epidemiological studies and other 
analyses were subsequently performed that could not 
confirm this causal relationship.11,12  
 
Girard has questioned the methods used and the 
conclusions issued after the controlled studies, 
highlighting that not all cases of autoimmunity 
associated with this vaccine were collected, and the 
inappropriateness of the statistical methods used.13 
However, Bogdanos et al. reported that several 
patients vaccinated against hepatitis B developed 
antibodies against myelin oligodendrocyte protein 
mimetic peptides; however, no clinical consequences 
of this cross-reactivity were detected and the 
antibodies decreased their titer in the subsequent 
months. No anti-MBP peptide antibodies14 were 
detected in this same study. This supports the 
criterion that an autoimmune reaction does not 
always have a clinical translation, which further 
complicates interpretation of the results. The actual 
danger of hepatitis B vaccination is still debated, and 
it is generally accepted that if a true causal 
relationship exists in practice, the benefits reported 
for this vaccine outweigh the potential risk. The 
existence of autoimmune phenomena associated with 
natural hepatitis A infection is known, but in relation 
to hepatitis A vaccines, to date, one case of a possible 
connection to autoimmune hepatitis has been 
reported,15 so this vaccine is considered one of the 
safest, after millions of doses given worldwide. 
 
Guillain-Barré syndrome also called demyelinating 
polyradiculoneuritis, is closely related to a previous 
infection, with evidence of cross-immune reaction 
between viral antigens and myelinic antigens and 
constituting the most common autoimmune 
condition that has been related to influenza 
vaccines.16 The relationship of GBS to influenza 
A/New Jersey vaccine was suggested following a 
vaccination campaign conducted in the United States 
between 1976 and 1977, during which the number of 
cases of this condition increased in the first weeks 
after vaccination, particularly in the fifth week, with 
the incidence decreasing after the sixth week, leading 
to a temporary suspension of the vaccination 
program.17  
 
However, retrospective research developed after 
campaigns conducted in 1992–1993 and 1993–1994 
revealed that the incidence within six weeks was 
significant although much lower than in the 
campaign of the 1970s.18 Another found a significantly 
increased risk of developing GBS following influenza 
vaccination, with differences between vaccine 
producers and the viral strains used.19 Meanwhile, it 
has been shown that the risk of GBS recurrence 
following an initial episode and re-immunization 
with influenza vaccine is minimal. Influenza vaccine 
may also result in Henoch-Schönlein purpura, 
microscopic polyangiitis, reactive arthritis, giant cell 
vasculitis, polymyalgia rheumatica, 
cryoglobulinemia, polyarthralgia, fatigue, 
meningoencephalitis/encephalitis, optic neuritis, 
transverse myelitis, brachial neuritis, Guillain–Barré 
syndrome, Bell’s palsy, lymphocytopenia, 
thrombocytopenia, autoimmune hemolytic anemia, 
acute myocarditis, acute pericarditis, type 1 diabetes 
mellitus, nephrotic syndrome, uveitis, myositis, 
erythema multiforme.  
 
It has been suggested that immunization with H. 
influenzae type b vaccine after the age of two months 
may be related to type 1 diabetes in humans and that 
the potential risk of the vaccine may exceed the 
benefit it provides.20 However, this association has 
not been confirmed in controlled studies.(21) 
Hepatitis B vaccine might result in rheumatoid 
arthritis, reactive arthritis, SLE exacerbation, 
Sjogren’s syndrome, vasculitis, cryoglobulinemia, 
polyarthralgia, polyarteritis nodosa, myalgia, fatigue, 
erythema nodosum, erythema multiforme, cutaneous 
lupus erythematosus, localized scleroderma, lichen 
planus, encephalitis, acute aseptic meningitis, 
transverse myelitis, optic neuritis, neuropathy of 
lumbar and brachial plexuses, Guillain-Barré 
syndrome, Bell’s palsy, acute cerebellar ataxia, 
myasthenia gravis, multiple sclerosis, 
thrombocytopenia, immune hemolytic anemia, 
aplastic anemia, nephrotic syndrome, uveitis, 
alopecia, acute pericarditis and Graves’ disease.  The 
re-emergence of yellow fever has led to mass 
vaccination in countries such as Brazil, Australia, 
Spain, among others, with attenuated vaccines such 
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as 17D and 17DD, which have been very successful in 
their protective capacity; however, the occurrence of 
very sporadic conditions called viscerotropic and 
neurotropic diseases, have led to discussions about its 
safety.22 The mechanism of these severe adverse 
effects produced by these vaccines23 has not yet been 
determined, although it appears that people over 60 
years of age, and those with some predisposition or 
immunological compromise, exhibit an increased risk 
of these adverse events, so it is proposed to evaluate 
the risk/benefit of vaccination24 in these populations. 
These vaccines are generally considered safe and 
highly effective against this dangerous disease. 
Measles Mumps Rubella vaccine can cause arthritis 
and acute arthralgia, chronic arthritis, myositis, 
encephalitis, aseptic meningitis, myelitis, optic 
neuritis, Guillain-Barré syndrome, 
thrombocytopenia/acute thrombocytopenic purpura, 
hemolytic uremic syndrome, hemolytic anemia. 
Varicella vaccine is known to be associated with 
arthritis or arthralgia, vasculitis, encephalitis, aseptic 
meningitis, myelitis, optic neuritis, Guillain-Barré 
syndrome, transient cerebellar ataxia, optic neuritis, 
transverse myelitis, Bell’s palsy, thrombocytopenia, 
aplastic anemia, erythema multiforme. Poliomyelitis 
vaccine may induce acute arthritis, encephalitis, 
Guillain–Barré syndrome and autoimmune hemolytic 
anemia. Smallpox vaccine may cause post-vaccine 
encephalopathy, encephalomyelitis, erythema 
multiforme, myopericarditis, dilated 
cardiomyopathy. Diphtheria/tetanus toxoid is known 
to be associated with demyelinating diseases of the 
central nervous system and Guillain-Barré syndrome. 
BCG vaccine can cause Arthritis and Reiter’s disease. 
 
A latent concern of the health and regulatory 
authorities is the possibility that a vaccine may 
aggravate a pre-existing autoimmune disease. In this 
regard, several controlled studies, particularly in 
patients with multiple sclerosis, rheumatoid arthritis 
and SLE, using hepatitis B, influenza, pneumococcal 
and tetanus toxoid vaccines have not revealed 
evidence of worsening of the disease post-
vaccination,10 so there are no objective criteria to date 
that a patient-carrier of autoimmune disease must 
not be vaccinated. The development of an 
autoimmune process rests on the influence of genetic 
factors associated with external factors that induce or 
facilitate the loss of immunotolerance with the 
development of immune responses against its own 
structures. The genetic factor determines that not all 
individuals have the same predisposition to develop 
an autoimmune disease, among the most commonly 
involved genes are those that code for Human 
Leucocyte Antigens. There are reports of association 
of certain HLA haplotypes with autoimmune 
diseases, with HLA-B27 being the haplotype most 
associated with diseases such as ankylosing 
spondylitis.25 Other genes recently associated with 
autoimmune diseases are the autoimmune regulator 
genes, which participates in the presentation of self-
antigens during the central tolerance process in the 
thymus, for the deletion of autoreactive T-cells, the 
defect of which may lead to the development of multi-
systemic autoimmune diseases.26 Associations with 
polymorphisms have also been found in the gene 
encoding the cytolytic T lymphocyte associated 
antigen, a negative regulator in T-cell activation, and 
in the TIM (T-cell immunoglobulin and mucin-
domain-containing) family of proteins.27 Molecular 
mimicry in microbial antigens may constitute a 
potential hazard for the development of post-vaccine 
autoimmunity,1,6 especially in the presence of a 
vaccine adjuvant. Adjuvants optimize the immune 
response against the co-administered antigen, but 
also contribute to vaccine toxicity,28 so there is a 
hypothesis that certain autoreactive lymphocyte 
clones, which, under physiological conditions, do not 
recognize self-antigens due to being under the 
peripheral tolerance pressure, could well increase 
their ability to recognize and activate through the 
influence of adjuvant activity and develop an 
autoreactive response, especially in individuals with a 
favorable genetic background.29 Fortunately, the 
tolerance mechanisms are very effective in limiting 
the deleterious effect that molecular mimicry could 
cause between microorganisms and their own 
structures. Another mechanism that may act on post-
vaccine autoimmunity is the formation of immune 
complexes, causing vasculitis or exacerbation of 
latent autoimmune processes.10 
 
Lastly, it should be noted that within the dynamics of 
the immune response, usually responses against their 
own structures develop in a subclinical manner whose 
etiopathogenetic role is not yet known. Although 
there is theoretically the possibility of induction of 
post-vaccination autoimmune disease and the 
existence of documented suspicions of associations 
between certain vaccines and autoimmune 
conditions, epidemiological studies have mostly 
concluded that there is no such association or is of 
very low incidence. However, the epidemiological 
research required in vaccines currently has some 
issues, such as the lack of knowledge of the genetic 
profile of each vaccinated individual, since all genes 
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involved in autoimmunity have not yet been 
accurately defined. Another difficulty in the 
interpretation of population-based studies is that the 
timing of developing an autoimmune response is 
unpredictable. There is also a need to establish ways 
to improve the recording of adverse events in the 
pharmacovigilance studies, since these are performed 
through passive surveillance in which the patient 
spontaneously describes the event, which implies the 
problem that many people do not report and, 
furthermore, it is more difficult to establish a possible 
causal relationship with an event that occurs later as 
time passes after vaccination. All of this implies that 
refining analysis methods and having new elements 
in the pathogenesis of autoimmune diseases are 
necessary in order to establish the correct estimates. 
 
CONCLUSION 
Due to the great benefit to humanity achieved with 
vaccines, there is no justification for stopping or 
decreasing their administration. However, the 
potential risk of post-vaccine autoimmunity cannot 
be ignored and, although a clear causal relationship 
has not been established in practice, due to the ethical 
and medical-legal implications, it is a responsibility of 
medical field to continue refining evaluation methods 
from base level to pharmacovigilance studies and try 
to avoid potential adverse effects as much as possible, 
with greater rigor in the design and evaluation of 
vaccine candidates under development. 
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